SynVent is Syngene’s platform for fully integrated therapeutic discovery and development across large and small molecules.
Emerging biopharma work at the forefront of science, often venturing into disease areas where little or no real-world data exists to work with or regulatory frameworks to work within.
Our Dedicated Centers offer dedicated multi-disciplinary scientific teams, support personnel, and a tailormade ring-fenced and fire-walled infrastructure as per client specifications to support their R&D goals
Centre for Advanced Protein Studies [CAPS] is a state-of-the-art advanced national facility located in the Syngene campus, Bangalore.
Over the last decade, pets have moved from being household animals to becoming integral members of families. With this shift, expectations around veterinary care have also changed, especially in areas such as veterinary oncology, where pet owners increasingly demand advanced therapies for cancer, chronic inflammatory diseases, metabolic disorders, and age-related conditions in dogs and cats. […]
